Hyaluronated and PEGylated Liposomes as a Potential Drug-Delivery Strategy to Specifically Target Liver Cancer and Inflammatory Cells

Hepatocellular carcinoma (HCC) is the most frequent primary liver cancer and is characterized by poor clinical outcomes, with the majority of patients not being eligible for curative therapy and treatments only being applicable for early-stage tumors. CD44 is a receptor for hyaluronic acid (HA) and...

Descripción completa

Detalles Bibliográficos
Autores principales: Cannito, Stefania, Bincoletto, Valeria, Turato, Cristian, Pontisso, Patrizia, Scupoli, Maria Teresa, Ailuno, Giorgia, Andreana, Ilaria, Stella, Barbara, Arpicco, Silvia, Bocca, Claudia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8840578/
https://www.ncbi.nlm.nih.gov/pubmed/35164326
http://dx.doi.org/10.3390/molecules27031062

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8840578/
https://www.ncbi.nlm.nih.gov/pubmed/35164326
http://dx.doi.org/10.3390/molecules27031062

Ejemplares similares